Ribbon Biolabs Raises EUR 18 Million Series A Financing for DNA Synthesis Technology
VIENNA, AUSTRIA, January 31, 2022 -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in...
top of page
Search
Admin
- Jan 11, 2022
- 1 min
Merck leans into AI with $610M in biobucks for Absci drug discovery pact
VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company ...
Admin
- Jul 18, 2021
- 1 min
AbSci sets IPO terms, valuing company at up to $1.5 billion
AbSci Corp. ABSI, has set terms of its initial public offering, which could value the Washington-based provider of an artificial...
Admin
- Jul 14, 2021
- 1 min
Protein discovery and development platform AbSci sets terms for $200 million IPO
AbSci, which provides a platform for the discovery and development of proteins and biologics, announced terms for its IPO on Thursday....
Admin
- Jul 12, 2021
- 2 min
Helicase Venture portfolio company Absci files for IPO
https://seekingalpha.com/news/3711566-biotech-discovery-company-absci-files-for-ipo Absci Corp., a synthetic biology company whose...
Admin
- Jun 13, 2021
- 3 min
Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor
https://www.globenewswire.com/news-release/2021/06/14/2246385/0/en/Landos-Biopharma-Announces-Positive-Outcome-of-End-of-Phase-2-Meeting-...
Admin
- Jun 13, 2021
- 2 min
Totient, a Helicase Venture Portfolio Company, has been Acquired by AbSci
Totient, a Helicase Venture portfolio company, has been acquired by AbSci, a synthetic biology company unlocking the potential of...
Admin
- Mar 1, 2021
- 2 min
Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307
SAN DIEGO, March 2, 2021 – Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of...
Admin
- Feb 10, 2021
- 1 min
Pipeline Therapeutics Completes Oversubscribed $80 Million Series C Financing
SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of...
Admin
- Jan 14, 2021
- 2 min
Landos Biopharma guns for a $100M IPO to boost AI autoimmune R&D work
Landos is based upon the work of CEO Josep Bassaganya-Riera, Ph.D., a serial entrepreneur and Virginia Tech professor who outlined the...
Admin
- Jul 22, 2020
- 3 min
Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss
PIPE-505 is the first small molecule developed specifically for the treatment of sensorineural hearing loss (SNHL) associated with ...
bottom of page